Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-14 Purchase |
2022-04-18 11:46 am |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
14,160 | $0.894 | $12,659 | 59,003 (Direct) |
View |
| 2022-04-13 Purchase |
2022-04-13 9:43 pm |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
8,560 | $0.85 | $7,276 | 44,843 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-16 Option Award |
2022-12-19 5:04 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | Tegge Jonathan Interim CFO |
1,400 | $0 | 1,400 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 5:03 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | Li Sarah VP Accounting & Controller |
3,600 | $0 | 4,002 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 4:59 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | Johnson Shane Aaron Sr VP & General Manager |
4,200 | $0 | 8,000 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 4:58 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer |
7,500 | $0 | 11,342 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 4:54 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | Grove Janet P Director |
840 | $0 | 1,400 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 4:51 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director |
840 | $0 | 1,484 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 4:50 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | Baldasare Bryan T Director |
840 | $0 | 1,400 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 4:50 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
15,000 | $0 | 28,502 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 4:49 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
4,200 | $0 | 8,878 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-19 4:47 pm |
N/A 2027-12-15 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
4,200 | $0 | 8,152 (Direct) |
View |
Ownership |
2022-11-29 6:58 pm |
2022-01-12 2025-01-25 |
InMed Pharmaceuticals Inc. | INM | Li Sarah VP, Accounting and Controller |
0 | $0 | 402 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-15 7:52 pm |
N/A 2027-11-13 |
InMed Pharmaceuticals Inc. | INM | Johnson Shane Aaron Sr. VP & General Manager |
4,200 | $0 | 8,000 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-15 7:51 pm |
N/A 2027-11-13 |
InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer |
7,500 | $0 | 11,342 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-15 7:48 pm |
N/A 2027-11-13 |
InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
4,200 | $0 | 8,878 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-15 7:44 pm |
N/A 2027-11-13 |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
15,000 | $0 | 28,502 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-15 7:37 pm |
N/A 2027-11-13 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
4,200 | $0 | 8,152 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-10 8:14 pm |
N/A 2027-08-10 |
InMed Pharmaceuticals Inc. | INM | Lemerond Nicole Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2022-06-02 Expired |
2022-06-02 2:51 pm |
2017-06-02 2022-06-02 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
1,515 | $0 | 98,787 (Direct) |
View |
| 2022-06-02 Expired |
2022-06-02 2:50 pm |
2017-06-02 2022-06-02 |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
13,636 | $0 | 337,576 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:24 pm |
N/A 2027-05-16 |
InMed Pharmaceuticals Inc. | INM | Baldasare Bryan T Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2022-02-23 Option Award |
2022-02-28 2:20 pm |
N/A 2027-02-22 |
InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL See Remarks |
5,000 | $0 | 96,060 (Direct) |
View |
| 2022-02-20 Expired |
2022-02-23 4:42 pm |
2017-02-20 2022-02-20 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
3,030 | $0 | 100,302 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 8:16 pm |
N/A 2027-02-17 |
InMed Pharmaceuticals Inc. | INM | Grove Janet P Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2022-01-24 Expired |
2022-01-24 4:19 pm |
2016-06-10 2022-01-24 |
InMed Pharmaceuticals Inc. | INM | Garner William J Director |
24,242 | $0 | 16,122 (Direct) |
View |
| 2022-01-24 Expired |
2022-01-24 4:18 pm |
2016-05-16 2022-01-24 |
InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO |
121,212 | $0 | 763,030 (Direct) |
View |
| 2022-01-24 Expired |
2022-01-24 4:18 pm |
2016-10-28 2022-01-24 |
InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs |
12,121 | $0 | 103,332 (Direct) |
View |
| 2022-01-24 Expired |
2022-01-24 4:17 pm |
2016-09-12 2022-01-24 |
InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director |
30,303 | $0 | 16,122 (Direct) |
View |
| 2022-01-24 Expired |
2022-01-24 4:17 pm |
2015-11-23 2022-01-24 |
InMed Pharmaceuticals Inc. | INM | Cutler Adam D. Director |
30,303 | $0 | 95,335 (Direct) |
View |